Digital Therapeutics Market Growth

Digital Therapeutics Market Growth is expected at a CAGR of 19.59% during period 2023-2035 

 

According to a recently published report by Roots Analysis, the rising incidence of chronic diseases, the need for patient-centered solutions, and the integration of emerging technologies, is driving market growth

Digital Therapeutics Industry Overview

The global digital therapeutics market is anticipated to grow at a CAGR of 19.59% from 2023-2035, reaching USD 19.76 billion by 2035.

Digital therapeutics are software or mobile app-based solutions that have been clinically validated to help prevent, treat, or manage diseases or clinical conditions. These programs are designed to engage patients in personalized treatment or disease prevention by modifying their behavior or psychology, providing motivational support, and promoting healthy lifestyle changes. Further, digital therapeutics can work independently or in combination with personal medical assistance, such as a physician or an AI-based support system, healthcare devices, and other tools. They have been shown to be effective in addressing a variety of disorders, including lifestyle-related diseases, mental health problems, neurological disorders, and substance use disorders. Prescription digital therapeutic solutions are being developed by several companies and are generally prescribed by healthcare professionals or clinicians after confirming patient eligibility. Given the rising popularity of such solutions and emergence of several novel technologies, digital therapeutics developers are integrating advanced techniques to their respective portfolios in order to enable higher adoption.

To order this 560+ page report, which features 155+ figures and 205+ tables, please visit https://www.rootsanalysis.com/reports/digital-therapeutics-market/208.html

Market Drivers

The increasing prevalence of chronic diseases is fueling the need for digital therapeutics, which offer patient-centered solutions utilizing digital behavioral interventions, AI, machine learning, mobile health apps, gamification, and virtual reality. Moreover, the rising recognition of the advantages of digital therapeutics among healthcare providers, payers, and employers, along with pharmaceutical companies' growing interest in investing in treatment and care-related applications, is driving market expansion. Furthermore, the digital therapeutics market in North America is experiencing a significant upsurge in funding from government initiatives, private equity, and venture capital, further propelling its growth.

Market Restraints

Patient data security is a key concern in the digital therapeutics market, with a need to ensure the privacy and security of patient data within digital health applications. Additionally, regulatory compliance poses a significant challenge for the market, as it must adhere to diverse data privacy and security regulations. Further, the integration of digital therapeutics into healthcare systems and workflows is a complex and time-consuming process, potentially impeding market growth.

Growth Factors

Despite the challenges, several growth factors continue to drive the digital therapeutics market forward. The digital therapeutics market presents a wealth of opportunities for innovation and expansion, with many therapeutic applications yet to be explored. In fact, collaborations between digital therapeutics companies, healthcare providers, and research institutions are fueling revenue growth in the market. Further, the ongoing advancement of cutting-edge technologies, including AI, machine learning, and virtual reality, offers the digital therapeutics market opportunities to enhance and broaden its existing products. Additionally, the digital therapeutics market has the potential to experience substantial growth in developing countries, where there is a pressing need to improve healthcare access and outcomes.

Digital Therapeutics Market Segments

Based on type of solution, the digital therapeutics market is segmented into standalone software application, software application + device, software application + AI support, software application + personal coach, software application + device + AI support, software application + device + personal coach and others

• The standalone software application segment in digital therapeutics market capture the largest revenue share of 35.5% in 2023.
• The software application + device + AI support segment is anticipated to show the highest market growth potential during the forecast period of 26.24% annually.

Based on the type of therapy, the digital therapeutics market is segmented into curative solutions and preventive solutions

• The curative solutions segment led the digital therapeutics market, capturing the largest revenue share of close to 84.45% in 2023.
• In fact, the curative solutions segment is anticipated to show the highest market growth potential during the forecast period of 20.33% annually.

Based on the purpose of solution, the digital therapeutics market is segmented into medication replacement and medication augmentation

• The medication replacement solutions segment led the digital therapeutics market, capturing the largest revenue share of 63.76% in 2023.
• In fact, medication augmentation solutions is anticipated to show the highest market growth potential during the forecast period of 20.43% annually.

Based on the type of type of business model, the digital therapeutics market is segmented into B2B and B2C

• The B2B segment led the digital therapeutics market, capturing the largest revenue share of 65.79% in 2023.
• In fact, the B2B segment is anticipated to show the highest market growth potential during the forecast period of 21.14% annually.

Based on therapeutic area, the digital therapeutics market is segmented into cardiovascular disorders, chronic pain, mental health problems, metabolic disorders, neurological disorders, respiratory disorders, sleep disorders, substance use disorders and other disorders

• The metabolic disorders segment led the digital therapeutics market, capturing the largest revenue share of close to 24.27% in 2023.
• The neurological segment is anticipated to show the highest market growth potential during the forecast period of 23.85% annually.

Based on the regional insights, the digital therapeutics market is segmented into North America, Europe, Asia, Middle East and North Africa, Latin America and rest of the world

• North America dominated the market and accounted for the largest revenue share of over 41.36% in 2023.
• In Asia and Latin America the digital therapeutics market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The report also includes detailed profiles of key players (listed below) that offer digital therapeutics:

• Ampersand Health
• Akili Interactives
• Better Therapeutics
• Brain+
• Click Therapeutics
• CogniFit
• GAIA
• Healios
• JOGO Health
• Jolly Good
• KORE Digital Health Therapeutics
• Livongo Health
• Lucid
• MedRhythms
• Pear Therapeutics
• Redicare Control
• Susmed
• The Learning Corp
• Voluntis
• WellDoc

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com